Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire an unknown majority stake in Pentavere Research Group Inc. from Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others for CAD 5.9 million on November 14, 2023. HEALWELL is buying an initial stake from existing shareholders with a combination of cash (CAD 1.75 million) and AIDX stock (CAD 4.16 million) using the 5-day VWAP of the Subordinate Voting Shares prior to announcement of the transaction. A further CAD 1.2 million will be invested by HEALWELL on closing to purchase newly issued treasury shares that increase HEALWELL's ownership to a majority position on a non-diluted basis, and provide Pentavere with fresh operating capital. On closing, HEALWELL has the right to appoint nominees for a majority of Pentavere?s board seats. Transaction is expected to close on December 1, 2023.

Healwell AI Inc. (TSX:AIDX) completed the acquisition of an unknown majority stake in Pentavere Research Group Inc. from Christopher Pettengell, Aviva Pratzer, Mark Harris, Steven Aviv, Hilton Silberg, AAron Leibtag and others on December 4, 2023. The transaction is expected to be financially and strategically accretive and highly synergistic with HEALWELL?s strategic alliance agreement with WELL Health Technologies Corp.